Globe Life's Q2 2026 net income rose 13.8% to $287.7M ($3.65/share, +20%) on 16% health premium growth, wider life margins and buybacks; life net sales fell 3% and 2026 guidance was raised to $15.55–$15.95.
Revenue
$1.6B
+8.0% YoY
Net income
$288M
+13.8% YoY
Diluted EPS
$3.65
+19.7% YoY
Overview
Globe Life sells basic life insurance and supplemental health insurance to lower-middle and middle-income US households. In the second quarter of 2026 (April–June), total revenue rose 8.0% to $1.60 billion and GAAP net income rose 13.8% to $287.7 million, or $3.65 per diluted share (up 19.7%). Two things did most of the work: health premiums jumped 16%, led by Medicare Supplement policies sold through the United American Division, and life insurance got more profitable per dollar of premium.
Per-share growth ran ahead of profit growth for two reasons. First, Globe Life keeps buying back its own stock, so each share owns a bigger slice: diluted shares averaged 78.9 million versus 82.8 million a year ago. Second, the bond portfolio swung from a $14.7 million after-tax realized loss in Q2 2025 to a $5.6 million after-tax gain this quarter. That swing is one-off investment noise, not insurance performance. Net operating income is management's measure that strips out investment gains/losses and legal items. It rose a more modest 5.0% to $284.7 million, or $3.61 per share (up 10%).
Management raised full-year 2026 earnings guidance to $15.55–$15.95 per share, $0.10 higher at the midpoint.
Key metrics
Metric
Q2 2026
Q2 2025
YoY Change
Total revenue
$1,599.7M
$1,481.3M
+8.0%
Total premium
$1,297.6M
$1,217.6M
+6.6%
Life premium
$860.8M
$839.5M
Read 0 community reports on Globe Life, or write your own.Write a report
Underwriting margin is what's left of premiums after paying policyholder claims and reserves ("policy obligations") and the cost of selling the policies (commissions and acquisition costs). It shows how profitable the insurance itself is, before investment income, overhead, debt interest and tax.
Net sales is the annual premium on newly issued policies, minus policies cancelled within 30 days. Premium revenue is what the company collects on everything already in force; net sales shows how fast new business is being added, so it signals where premium growth is heading.
Excess investment income is what the investment portfolio earns beyond the interest the company has to credit to its policy reserves. It is the investment business's actual profit.
Life insurance: flat sales, better margins
Life premium rose 2.5% to $860.8 million. The larger gain was in profitability: life underwriting margin rose 5.7% to $359.4 million, or 42% of premium versus 41%. Life policyholder benefits actually fell to $514.0 million from $519.4 million even though premium grew. According to the 10-Q, that reflected "lower policy obligations as a percent of premium." Part of the drop is an accounting item. Each quarter insurers update their reserve estimates for actual claims and policyholder behavior (a "remeasurement"). This quarter's update produced a $23.5 million pre-tax gain for life, against $16.7 million a year ago. That $6.8 million difference explains roughly a third of the $19.3 million increase in life margin.
By division:
Life division
Q2 2026 premium
YoY
Q2 2026 margin (% of premium)
Margin YoY
Net sales YoY
American Income
$466.3M
+5%
$213.6M (46%)
+4%
−2%
Direct to Consumer
$244.2M
−1%
$75.9M (31%)
+10%
−15%
Liberty National
$100.5M
+3%
$36.7M (36%)
+10%
+6%
American Income (sold by an exclusive agent force, mainly through labor unions and other affinity groups) is the largest division, with 54% of life premium. Premium grew 5%, but net sales fell 2% and the average number of producing agents fell 7% to 11,391. The 10-Q attributes the agent decline to "lower retention of new agents." Agent count did rise from 11,064 in Q1, and this is the number to watch: management says long-term sales growth in its agencies "is generally tied to expansion of the agency force."
Direct to Consumer (direct mail and online) had the weakest sales, down 15% in the quarter to $26.6 million. The 10-Q gives an unusually specific reason: growing use of AI in consumer search "has reduced paid search volume from internet marketing." Margin still rose to 31% of premium from 28%. The 10-Q credits favorable mortality, meaning fewer deaths than expected.
Liberty National grew on every measure: 8% more producing agents (4,194), 6% higher net sales, and a margin up to 36% from 34%. The 10-Q also credits favorable mortality here.
Health insurance: fast growth, thinner margins
Health premium rose 15.5% to $436.9 million, mostly from United American, where premium grew 29% to $211.4 million. United American sells Medicare Supplement policies through independent agents. Medicare Supplement covers costs that original Medicare doesn't pay. The 10-Q attributes the growth to more people turning 65, "a notable migration of Medicare beneficiaries from Medicare Advantage to Medicare Supplement plans," and approved rate increases.
That growth came at lower margins. United American's underwriting margin fell 12% to $10.9 million, just 5% of premium (8% a year ago). Its products pay out a larger share of premium in claims than Globe Life's other health products. As United American becomes a bigger part of the health book, the overall health margin falls with it: 23% of premium this quarter versus 26%. The 10-Q also says the group health business built on the Evry Health acquisition is new and may produce volatile results as it scales.
Family Heritage (supplemental cancer and critical-illness policies sold to small and mid-sized businesses) grew health premium 9%, underwriting margin 10% to $45.1 million (36% of premium), and net sales 4%, with 7% more producing agents.
Investments, expenses and capital
Excess investment income rose 10% to $38.3 million. Net investment income grew 4% while required interest on policy reserves grew 3%. The fixed-income portfolio's yield was essentially flat at 5.30% (5.29% a year ago). New bond purchases in the quarter yielded 6.3%, so new money is being invested above the portfolio average.
Administrative expenses were 7.0% of premium versus 7.1%.
Buybacks: 1.1 million shares were repurchased for $175 million (average $154.28), and 2.6 million shares for $378 million in the first half. $736 million remained under the board's authorization at June 30.
Book value per share rose 18% to $78.18. Excluding AOCI (unrealized bond gains/losses and discount-rate effects that swing with interest rates), it rose 11% to $100.04.
Debt: in June the company amended its term loan, raising it to $450 million from $250 million and extending maturity to 2029. It also extended its $1 billion revolving credit facility.
Takeaway: The quarter's earnings growth came from higher life margins, helped partly by a larger reserve-remeasurement gain and favorable mortality, and from buybacks shrinking the share count. It did not come from new business. Life net sales fell 3% and American Income's agent force shrank 7%. The fastest-growing line, United American's Medicare Supplement, earns only about 5 cents of underwriting margin per premium dollar.
Outlook
Management raised full-year 2026 guidance to $15.55–$15.95 per share, $0.10 higher at the midpoint. The release announces the raise alongside net operating income per share, which was $7.04 for the first half. Measured against that, the range implies roughly $8.51–$8.91 in the second half, a faster pace than the first half. Continued buybacks and premium growth would be consistent with that.
The main risk to that path is the sales pipeline. Life premium grows only about as fast as new sales replace lapsing policies, and Q2 life net sales fell 3.4%. The two items to watch in Q3 are whether American Income's agent count keeps recovering from its Q1 low, and whether Direct to Consumer can adapt its marketing to AI-driven search. On the health side, United American will keep adding premium, but at low margins. Its effect on earnings is much smaller than its effect on revenue growth.
Source: Globe Life Form 10-Q for the quarter ended June 30, 2026 (filed 2026-08-05) and the Q2 2026 earnings release (Form 8-K Exhibit 99.1, July 22, 2026).